Palatin Technologies, Inc.

Direct answer

Palatin Technologies, Inc. is publicly traded on NASDAQ under the ticker PTN.

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as...

Can you invest in Palatin Technologies, Inc.?

Yes. Palatin Technologies, Inc. is publicly traded on NASDAQ under the ticker PTN.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Palatin Technologies, Inc.

Detailed equity research is provided by MarketSnap.